Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EMED- A Company with a future. -- Ignore unavailable to you. Want to Upgrade?

To: despy who wrote (35)	3/9/2000 10:08:00 AM
From: CIMA	Read Replies (1) \| Respond to of 65

Thursday March 9, 9:04 am Eastern Time Company Press Release MedCom USA, Inc. Announces Agreement to Acquire DCB Actuaries & Consultants IRVINE, Calif.--(BW HealthWire)--March 9, 2000--MedCom USA, Inc. (Nasdaq:EMED - news) announced today that it has signed a letter of intent to acquire DCB Actuaries & Consultants. DCB is a member of an international network of actuarial consulting firms, Woodrow Milliman, an international network of actuarial and consulting firms represented in 34 countries, employing over 3,000 people worldwide. DCB was formed in 1991 and currently employs approximately 65 professionals, primarily highly qualified software engineers, actuaries and consultants. ``The acquisition is expected to be very beneficial to MedCom; in a single transaction, MedCom will now have the capability to provide a comprehensive technological solution to many of the problems currently plaguing the healthcare environment. Other companies have been trying to build an organization that can offer the capability of DCB's current products. We will be able to offer these services without the integration and development issues facing these other groups, since DCB is already operating such a system overseas. Their system is operational and it works,' said Mr. Mark E. Bennett, President and CEO of MedCom USA, Inc. DCB developed and currently operates a health insurance decision support system with advanced data-structures covering 35 dimensions of attributes. The health insurance data warehouse consists of a three-year history of over 100 million care performance records, representing 1.6 million insured lives. The system combines the Teradata data warehouse with MicroStrategy's relational OLAP architecture data mining tools to provide an effective application for browsing and analyzing the high volumes of data and, subsequently, for making the best use of the knowledge gained. DCB has formed associations and relationships with many top companies, including Woodrow Milliman, MicroStrategy, Bacon & Woodrow and NCR Corporation. DCB is identified as a partner on MicroStrategy's web site. ``DCB's products will be valuable tools for the US healthcare industry. They can function in a hospital or provide valuable data for insurance providers. The intuitive outcomes statistics data functions are extraordinary. The only piece that DCB was missing was the insurance billing and verification, and we have that segment with our MedCard System. We are working with the same potential customers and contacts. That is why this is such an ideal match. By closing this single transaction we will leapfrog ahead in many aspects of healthcare technology. DCB's addition to MedCom will go hand in hand with our existing and planned products and services. We will be able to capitalize on this wealth of talent to expand on the development of our other projects, including the MedCard System,' added Mr. Bennett. DCB's Evidence Based Medicine Systems (EBMS) allow a physician to monitor a patient's status from their home or office. They can view x-rays, EKG's and other critical data at any time. Patients' entire history can be made available to the attending physician. Plus, each patient's course of treatment can be separately tracked and even monitored against a standard course of action based upon the patient's conditions and symptoms through the outcomes data functions. However, DCB's products provide more than just patient information. They can provide the hospital or insurance provider vital financial data about their operations. These organizations will be able to receive more comprehensive and better data at the touch of a button. DCB's Health Infocenter and Health Data Analyzer applications move health care organizations beyond traditional e-business to Intelligent E-Business, while increasing effectiveness and quality of health care services, strengthening customer/patient loyalty and creating virtual health care organizations and health insurance companies' concepts by replicating the functionality of a live standard organization. The fully integrated Web interface systems can access different types of data -- structured and non-structured -- stored in a variety of data sources via standard Internet communication devices (i.e. automatically generating a personal Web page or E-mail). This live Business Intelligence and E-Commerce solution allows the user to analyze, personalize, subscribe and distribute health care information and data via different devices for different types of users. Beside business intelligence and e-commerce applications, DCB has developed special data statistical applications that sit on top of large data warehouse databases. The Analytical Module is designed to provide users with advanced statistical analysis over large health care data sets. The Treatment Episode and Profiling Analyzer create dynamic (multi-variant) treatment pathways from the atomic claims data in the data warehouse according to different risk adjustment factors. They generate multi-paramater benchmarks for ``best Practice', risk adjusted performance and quality for provider profiling. MedCom will acquire 100% of the stock of DCB, which is based in the Czech Republic, in a transaction that will be accounted for as a purchase. The terms of the transaction were not disclosed. The acquisition, which is subject to the successful completion of due diligence by MedCom, is expected to close in the quarter ending June 30, 2000. DCB currently has other projects and proposals in other European countries, including the UK, as well as the US. For the year ended December 31, 1999, DCB's unaudited revenues totaled approximately 85,500,000Kc (US $2,500,000). MedCom USA, Inc. provides innovative solutions for electronically processing transactions within the healthcare industry. The Company's healthcare business units include: MedCard, a service package for physicians, clinics and hospitals that has been endorsed by the New York County and Suffolk County Medical Associations; JustMed.com, a pure play Internet healthcare Web site; and Med Store, an e-commerce site for selling home medical equipment (HME) products. MedCom's Internet address is www.medcom.net and MedCom's healthcare portal is www.justmed.com. NCR and Teradata are trademarks or registered trademarks of NCR Corporation (NYSE:NCR - news) in the United States and other countries. MicroStrategy and Intelligent E-Business are either trademarks or registered trademarks of MicroStrategy Incorporated (NASD:MSTR - news) in the United States and certain other countries. This release contains forward-looking statements that are subject to risks and uncertainties, including but not limited to, the impact of competitive products and pricing, product demand and market acceptance, reliance on key strategic alliances, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. -------------------------------------------------------------------------------- Contact: MedCom USA Fegen and Associates Nick Fegen, 515/223-6296 or Kent Barghols, 515/331-2636

To: despy who wrote (35)	3/26/2000 11:01:00 AM
From: CIMA	Respond to of 65

From Raging Bull: By: Despy Reply To: 2786 by SouthFlorida Sunday, 26 Mar 2000 at 1:55 AM EST Post # of 2798 EMED is a solid company. It has consistantly improved its earnings and most of us are expecting positive reports on quarter 2 earnings. It has a profitable business plan with mutiple product lines. One of the product lines you will hear me rave about is sold by their financial services devision. EMED is currently applying for national contracts with the federal government to process 3rd party claims to Medicare. With that accomplishment out of the way, the company will be able to provide electronic claim submission on behalf of doctors offices wanting to get paid by both Medicare and private payors quicker. Medicare will pay doctor's in 14 days if the claim is transmitted electronically. If claim is mailed, it is subject to data entry errors and subject to 30 day payment terms. There are several competitors but only one to worry about. Medicare will sell the software to allow a doctor to transmitt electronically. Its downfall is that the doctor can not use the software for any other third party payor and must use a seperate billing program when billing private insurances. Rather than pay for two programs, most doctors mail the claims. Other products on the market consist of expensive customized software that will transmit electronically to medicare and print UB92 or HCFA 1500 claim forms that can be mailed to private insurance carriers. However, these products do not transmitt to "private" carriers. I have worked in the Medical Billing industry for over 10 years and seen a number of different accounting packages. EMED is the first company to attempt to make one product that can bill both Medicare and Private carrierss via electronic claim submissions. This requires interfacing with each potential payor's computer software. In the past, computers just didn't have the same compatibility options as they do now. Emed is continueing to negotiate with 3rd party payors to expand its product attractiveness. EMED's distinct advantage is in its "dual" marketing plans and affordability of claim filing software. By selling the financial services, EMED can also offer doctors lower prices on Medical supplies utilizing economies of scale. The low-cost of the financial services will drive sales of other products and vice versa. Electronic claim submission products can be sold for less than the cost of a stamp. This is not a "fly by night" Get rich quick plan. EMED's goals to eleminate paper claims will become a reality. It is not a question of if? It is a question of when? And who? Who will have largest market share. Use Yahoo and search for "Medical Billing Company" or "Accounts Receivable Managers." I did and was surprised at the results. Another selling concept is that doctors will not need the same number of office staff to mail and follow up on collecting the A/Rs if he/she utilizes a billing software that interfaces with his own accounting system and electroncially tracks his claims. EMED can carve a nich here. Several companies are attempting similar plans. EMED is not trying to compete with companies like WebMD. This market is largely "UNTAPPED" and will remain so for the next five to ten years. There is plenty of room to grow. If you want to see another company offering similar products, look at www.medscape.com. They seem most likely to be a viable competitor. Don't be scared of Medscape. They just dont have the same ideas. Medscape's billing system requires that the doctor leave confidential accounting and patient information on their company website. I dont think doctors will be willing to trust a an accounting system that saves confidential patient amd accounting data on an internet web server. MEDSCAPE takes away the doctor's options. EMED simply utilizes the net to transmit claims form the computer in the doctor's office to a computer in a medicare office or private insurrer. With EMED, The doctor still keeps the data and can bail at any time. MEDSCAPE is also targeting a different healthcare product sector. They are trying to allow the physician to transfer entire medical records via the internet for use by Managed care organizations. Currently their is a huge devide in the medical industry as a whole. MCOs on one side, and proividers on the other. The problem with catoring to MCOs is that most of them are filing chapter 11. I cant imagine a business that relies on bankrupt clients becomming a threat to EMED. Medscape is not pounding the pavement signing up physicians. EMED already has providers on their client list that are utilizing the above products. That list is continueing to grow. I see their service becomming a fad in the medical industry without significant competition. However; assuming others will compete successfully, THIS market is HUGE ! ! You only need about 5% of the market share to make good money off the residuals here. The closest analogy I can think of would be if GM bought BP. They make money on selling the car... and they make money selling the gas. I like emed because of its financial services. Other's like it because one of the divisions, JUSTMED.COM, is schedualed to be sold to the public. That alone will rocket the stock north on the short run regardless of market share. Regardless. This is a risk. Investing can be rewarding and punishing. GL... Let us know what you decide.